Healthcare -
Biotechnology - NASDAQ - US
$ 5.25
8.25 %
$ 111 M
Market Cap
-0.96
P/E
ENTA - SELLING, GENERAL & ADMINISTRATIVE
Selling, General & Administrative ENTA - Enanta Pharmaceuticals, Inc.
57.8 M
LAST VALUE
12.78%
2 YEAR CAGR
17.12%
5 YEAR CAGR
19.17%
10 YEAR CAGR